Publications and Presentations Database
T
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Cupples, L. A., et al.
(2010).
Telephone and in-person disclosure of genetic test results: 6-week recall, comprehension, and distress among participants in the REVEAL Study.
P
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al.
(2010).
The psychological impact of learning APOE ε4 increases the risk for cardiovascular disease during genetic risk assessment for Alzheimer’s disease: Findings from the REVEAL Study.
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Royal, C. D. M., Obisesan, T., et al.
(2010).
Perceived personal utility of Alzheimer’s disease genetic susceptibility testing and its influence on post-test responses: Findings from the REVEAL Study.
LaRusse, S., Katzen, H., Brown, T., Barber, M., Whitehouse, P. J., Green, R. C., et al.
(2002).
Participant recall of their own apolipoprotein E (APOE) genotype and risk estimate after six weeks: Results from the REVEAL Study.
I
Christensen, K. D., Roberts, J. S., Royal, C. D. M., Fasaye, G., Obisean, T., Cupples, L. A., et al.
(2007).
Incorporating Ethnicity into Genetic Risk Assessment for Alzheimer's Disease: The REVEAL Study Experience.
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al.
(2009).
The Impact of Pleiotropic Information about Cardiovascular Disease Risk on Health Behavior Changes among People Seeking Genetic Susceptibility Testing for Alzheimer’s Disease: Initial Results from a Randomized Trial.
Christensen, K. D., Roberts, J. S., Royal, C. D. M., Cupples, L. A., Whitehouse, P. J., Relkin, N. R., et al.
(2008).
The Impact of an Education and Risk Evaluation Protocol on Perceived Benefits, Risks and Limitations of Genetic Susceptibility Testing for Alzheimer's Disease.
H
Green, R. C., Roberts, J. S., Brown, T. C., Whitehouse, P. J., Barber, M., Relkin, N. R., et al.
(2002).
How many adult children of patients with Alzheimer’s disease will choose genetic susceptibility testing with APOE genotyping?.
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., Whitehouse, P. J., Obisesan, T., Bhatt, D. L., et al.
(2010).
How does pleiotropic information affect health behavior changes? Initial results from the REVEAL Study, a randomized trial of genetic testing for Alzheimer’s disease.